Report: Increases in Drug Rebates Associated with Rise in list Prices
February 27th 2020According to a new report from the Leonard D. Schaeffer Center for Health Policy and Economics, a $1 increase in drug rebates was associated with a $1.17 rise in list prices, hurting uninsured patients who pay list prices and insured patients who pay coinsurance and deductibles based on list prices.
Read More
Awaiting Supreme Court Ruling on Regulations, States Aim to Legislate PBMs On Their Own
February 25th 2020As the Supreme Court prepares to hear oral arguments in Rutledge v. Pharmaceutical Care Management Association (PCMA), several states are moving forward with their own legislation to limit the influence of pharmacy benefit managers (PBMs) in managed care organizations.
Read More
Study Results Link Postpartum Depression to Inflammation
February 25th 2020The results of a recent study published in Brain, Behavior, and Immunity suggest that inflammation and the kynurenine pathway may be connected to postpartum depression (PPD) and therefore may present new treatment targets in severe PPD.
Read More
Despite Increase in COVID-19 Cases Outside China, WHO Says the Virus is Not Yet a Pandemic
February 24th 2020In a press briefing, WHO Director-General Tedros Adhanom, PhD, said the decision to declare a pandemic is based on ongoing assessments of the geographic spread, the virus’s impact on overall society, and the severity of the illnesses.
Read More
Clinical Evidence Exists for Allopregnanolone-based Treatments
February 24th 2020With the recent approval of a Zulresso, an allopregnanolone-based treatment for postpartum depression (PPD), many pharmacists and physicians have been researching the mechanisms and other information about the drug.
Read More
US Coronavirus Cases Jump to 34, Possible Asymptomatic Carrier Transmission Reported
February 22nd 2020As countries across the world enact policies to limit the scope of the novel coronavirus (COVID-19), a report of transmission via an asymptomatic carrier could make prevention more difficult and increase global concerns.
Read More
Politicians on both sides of the aisle have long been debating key issues in modern health care, including rising drug prices, access to care, and national addiction rates. Despite some agreement on which issues are most pressing, arguments persist in how to address them heading into the 2020 presidential election.
Read More